Il Giorno: Enthera, 35 million for a drug to treat diabetes
Date: 7 February 2021
The funding comes from a pool of international investors convinced by the Enthera’s research.

Panorama: From Italy the cure for T1D: Dall’Italia la cura contro il diabete di tipo uno – Panorama
Date: 2 February 2021
A drug, created and studied in Italy, could free diabetics from the famous insulin shot.

Il Corriere della Sera: Enthera, fundraising record of 35 million
Date: 28 January 2021
Record funding for the Italian biotech Enthera started by Silvano Spinelli and led by CEO Giovanni Amabile.

StartUs Insights: 5 Top Gastrointestinal Drug Startups Impacting The Pharma Sector
Date: 18 December 2020
StatUs Insights analyzed 153 gastrointestinal drug startups impacting the pharma sector. OrphoMed, Enthera, Edesa Biotech, Scioto Biosciences & BiomX clinical assets were identified as 5 top solutions to watch out for.

Business Insider: 21 biotech startups that are set to take off, according to top VCs
Date: 13 August 2020
Link: Business Insider

Enthera named as a start-up poised to take off in the next year by a top biotech venture capitalist due to its work on developing innovative therapeutics for Type 1 diabetes and inflammatory bowel disease.

Download PDF